1 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版). 肝脏,2011,16: 2-16.
2 Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology, 2007,45:507-509.
3 Jia H, Ding F, Chen J, et al.LAM add-on ADV combination therapy or ETV monotherapy for CHB patients with suboptimal response to ADV. Ann Hepatol, 2015,14:175-180.
4 Chen CH, Wang JH, Lu SN, et al.Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants. Antivir Ther, 2012,17:701-709.
5 Kang SH, Yim HJ, Kim HR, et al.Comparison of lamivudine plus adefovir therapy versus entecavir with or without adefovir therapy for adefovir-resistant chronic hepatitis B. J Clin Gastroenterol, 2014,48:889-895.
6 Heo NY, Lim YS, Lee HC, et al.Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir. J Hepatol, 2010,53:449-454.
7 Fung SK, Chae HB, Fontana RJ, et al.Virologic response and resistance to adefovir in patients with chronic hepatitis B. J Hepatol, 2006,44:283-290.
8 Keeffe EB, Zeuzem S, Koff RS, et al.Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroenterol Hepatol, 2007,5:890-897.
9 Kwak MS, Choi JW, Lee JS, et al.Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir. J Viral Hepat, 2011,18:e432-438.
10 Berg T, Zoulim F, Moeller B, et al.Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients. J Hepatol, 2014,60:715-722.
11 Tan J, Degertekin B, Wong SN, et al.Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. J Hepatol, 2008,48:391-398.
12 12 Lim YS, Yoo BC, Byun KS, et al. Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial. Gut, 2015,[Epub ahead of print].
13 Park JH, Jung SW, Park NH, et al.Efficacy of tenofovir-based rescue therapy in lamivudine-resistant chronic hepatitis B patients with failure of lamivudine and adefovir combination. Clin Ther, 2015, 37: 1433-1442.
14 Lok AS, McMahon BJ. Chronic Hepatitis B: Update 2009. Hepatology, 2009,50:661-662.
15 庄辉,翁心华. 核苷和核苷酸类药物治疗慢性乙型肝炎的耐药及其管理. 中华肝脏病杂志,2013,21:15-22.
16 Lok AS, Zoulim F, Locarnini S, et al.Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology, 2007,46:254-265. |
